Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05705219

Development of 3DMPUS as a Decision Support Tool for Patients With Liver Tumors Undergoing Therapy — 3DMPUS  

Liver Cancer, Adult Clinical Trial

Official title:
Development of 3DMPUS as a Decision Support Tool for Patients With Liver Tumors Undergoing Therapy

Clinical Trial Summary

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response. 3D-MPUS is an inexpensive and safe method, which may provide complementary quantitative functional (perfusion) and tissue characterization information to anatomical radiological assessment or blood biomarkers.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05705219
Study type Interventional
Source Stanford University
Contact David Marcellus, BS
Phone (650) 723-4547
Email dmarcel2@stanford.edu
Status Recruiting
Phase N/A
Start date December 4, 2023
Completion date December 31, 2027
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02967848 - Liver Function Investigation With SPECT
Recruiting NCT03674073 - A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma Phase 1
Terminated NCT02704130 - TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma N/A
Recruiting NCT04864054 - T-Cell Therapy (ECT204) in Adults With Advanced HCC Phase 2
Not yet recruiting NCT05195294 - Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC Phase 1/Phase 2
Completed NCT02191878 - Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma Phase 1/Phase 2
Terminated NCT00669136 - Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma Phase 1
Active, not recruiting NCT04567615 - A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors Phase 2
Terminated NCT02527577 - Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection. N/A